- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Anu Sharma
Total 63807 results
-
LEO PharmaCompletedSecondary HyperparathyroidismGermany, Poland
-
LEO PharmaWithdrawn
-
LEO PharmaWithdrawnAtopic DermatitisNetherlands
-
LEO PharmaTerminated
-
UCB PharmaCompletedEpilepsyUnited States, France, Hungary, Mexico, Poland
-
LEO PharmaCompleted
-
LEO PharmaCompletedPsoriasis VulgarisFrance
-
LEO PharmaCompletedDeep Vein ThrombosisBulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
-
MaaT PharmaTerminatedIntensive Care Units | Fecal Microbiota TransplantationFrance
-
Iltoo PharmaCompletedSystemic Lupus ErythematosusFrance, Spain, Mexico, Austria, Germany, Bulgaria, Italy, Mauritius, Portugal, Romania
-
LEO PharmaCompletedAcne VulgarisUnited States
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompleted
-
LEO PharmaCompletedPsoriasis VulgarisUnited States, Canada, United Kingdom, Germany, Romania, France, Poland
-
UCB PharmaCompletedEpilepsyUnited States, Mexico, India, Brazil
-
LEO PharmaCompletedPlaque Psoriasis | Psoriasis VulgarisGermany
-
UCB PharmaCompleted
-
LEO PharmaCompletedSecondarily Infected Traumatic Lesions | ImpetigoUnited States, South Africa
-
UCB PharmaTerminatedCrohn's DiseaseUnited States, Germany, Canada
-
UCB PharmaCompletedCrohn DiseaseUnited States, Australia, Italy, Ukraine, Germany, Belgium, Israel, Romania, Canada, New Zealand, Brazil, Estonia, Russian Federation, Chile, Austria, Poland, Hungary, Latvia, Czechia, Finland
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Austria, Sweden
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Denmark, Austria, Norway, Sweden
-
Dermis PharmaCompleted
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Canada
-
UCB PharmaCompletedOpen Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisRheumatoid ArthritisUnited States, United Kingdom, Belgium, Germany, Austria, Ireland, Czechia
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Italy, Germany, Spain, Canada, Netherlands
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, Canada
-
UCB PharmaCompletedRheumatoid ArthritisGermany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
-
UCB PharmaCompletedFibromyalgia SyndromeUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompletedEpilepsyUnited States, Czechia, Germany, Poland
-
LEO PharmaTerminated
-
Kukje PharmaCompletedOcular Hypertension | Glaucoma | Eye DiseasesKorea, Republic of
-
Zealand PharmaCompleted
-
LEO PharmaCompleted
-
UCB PharmaCompletedEpilepsyFrance, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
-
LEO PharmaCompleted
-
Vifor PharmaCompletedChronic Heart Failure | Iron DeficiencyNetherlands
-
LEO PharmaCompletedAnogenital WartsDenmark
-
LEO PharmaCompleted
-
Zealand PharmaCompletedDiabetes Mellitus Type 1Germany
-
Innate PharmaTerminatedSquamous Cell Carcinoma of the Oral CavityGermany, Spain
-
Patara PharmaCompletedSystemic Mastocytosis | Mastocytosis | Indolent Systemic MastocytosisFrance, Germany, Spain, Italy, Netherlands